Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1

PLoS ONE

Volumn 2, Issue 12, 2007, Pages

  Haas Stapleton, Eric J ^a   Lu, Yan ^b,c   Hong, Song ^b,c   Arita, Makoto ^b,c   Favoreto, Silvio ^c   Nigam, Santosh ^d   Serhan, Charles N ^b,c   Agabian, Nina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 MONOOXYGENASE INHIBITOR; INTERLEUKIN 8; LIPID; LIPOXYGENASE; REACTIVE OXYGEN METABOLITE; RESOLVIN E1; 5S,12R,18R TRIHYDROXY 6Z,8E,10E,14Z,16E EICOSAPENTAENOIC ACID; 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; DRUG DERIVATIVE; ICOSAPENTAENOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CELL KILLING; CELL MOTILITY; CLEARANCE; COMMENSAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FUNGAL METABOLISM; FUNGAL VIRULENCE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INVASIVE CANDIDIASIS; LIPOGENESIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DRUG ANTAGONISM; LIQUID CHROMATOGRAPHY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; TANDEM MASS SPECTROMETRY; VIRULENCE;

CANDIDA ALBICANS; FUNGI;

ANIMALS; CANDIDA ALBICANS; CHEMOTAXIS, LEUKOCYTE; CHROMATOGRAPHY, LIQUID; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HUMANS; INTERLEUKIN-8; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; TANDEM MASS SPECTROMETRY; VIRULENCE;

EID: 44449173556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001316     Document Type: Article

References (41)

1. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, et al. (2000) Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellular processing. J Exp Med 192: 1197-1204.
2. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, et al. (2007) Resolution of inflammation: state of the art, definitions and terms. The FASEB journal 21: 325-332.
3. Park JY, Pillinger MH, Abramson SB (2006) Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clinical immunology (Orlando, Fla 119: 229-240.
4. Creelman RA, Mullet JE (1997) Biosynthesis And Action Of Jasmonates In Plants. 48: 355-381.
5. La Camera S, Gouzerh G, Dhondt S, Hoffmann L, Fritig B, et al. (2004) Metabolic reprogramming in plant innate immunity: the contributions of phenylpropanoid and oxylipin pathways. Immunological reviews 198: 267-284.
6. Howe GA, Schilmiller AL (2002) Oxylipin metabolism in response to stress. Curr Opin Plant Biol 5: 230-236.
7. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, et al. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 1025-1037.
8. Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869-874.
9. Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, et al. (2004) The diploid genome sequence of Candida albicans. Proc Natl Acad Sci U S A 101: 7329-7334.
10. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, et al. (2005) Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201: 713-722.
11. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, et al. (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Journal of immunology (Baltimore, Md 178: 3912-3917.
12. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, et al. (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 102: 7671-7676.
13. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, et al. (2006) RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. Faseb J 20: 401-403.
14. Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio KB, et al. (2006) Resolvin e2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin e series biosynthesis. Chem Biol 13: 1193-1202.
15. Arita M, Clish CB, Serhan CN (2005) The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun 338: 149-157.
16. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, et al. (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clinical infectious diseases 41: 1232-1239.
17. Mavor AL, Thewes S, Hube B (2005) Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Current drug targets 6: 863-874.
18. Fidel PL Jr (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Advances in dental research 19: 80-84.
19. Sheng WH, Wang JT, Lin MS, Chang SC (2007) Risk factors affecting in-hospital mortality in patients with nosocomial infections. Journal of the Formosan Medical Association = Taiwan yi zhi 106: 110-118.
20. Fidel PL Jr (2002) Immunity to Candida. Oral Dis 8 Suppl 2: 69-75.
21. Richardson MD (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56 Suppl 1: i5-i11.
22. Urban CF, Reichard U, Brinkmann V, Zychlinsky A (2006) Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cellular microbiology 8: 668-676.
23. Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173-182.
24. Ali A, Rautemaa R, Hietanen J, Jarvensivu A, Richardson M, et al. (2006) Expression of interleukin-8 and its receptor IL-8RA in chronic hyperplastic candidosis. Oral Microbiol Immunol 21: 223-230.
25. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M (1996) Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci U S A 93: 6682-6686.
26. Hillyer P, Mordelet E, Flynn G, Male D (2003) Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 134: 431-441.
27. Shen L, Smith JM, Shen Z, Hussey SB, Wira CR, et al. (2006) Differential regulation of neutrophil chemotaxis to IL-8 and fMLP by GM-CSF: lack of direct effect of oestradiol. Immunology 117: 205-212.
28. Rotstein D, Parodo J, Taneja R, Marshall JC (2000) Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock 14: 278-283.
29. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, et al. (2004) Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 104: 2557-2564.
30. Simons MP, Nauseef WM, Apicella MA (2005) Interactions of Neisseria gonorrhoeae with adherent polymorphonuclear leukocytes. Infect Immun 73: 1971-1977.
31. MacCallum DM, Odds FC (2005) Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48: 151-161.
32. Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual review of immunology 25: 101-137.
33. Chiang N, Serhan CN (2006) Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators. Methods in molecular biology (Clifton, NJ 341: 227-250.
34. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM (2005) Membrane microparticles: two sides of the coin. Physiology, Bethesda, Md 20: 22-27.
35. Fidel PL Jr, Barousse M, Espinosa T, Ficarra M, Sturtevant J, et al. (2004) An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infection and immunity 72: 2939-2946.
36. Weerasuriya N, Snape J (2006) A study of Candida esophagitis in elderly patients attending a district general hospital in the UK. Diseases of the esophagus 19: 189-192.
37. Erb-Downward JR, Huffnagle GB (2007) Cryptococcus neoformans produces authentic prostaglandin E2 without a cyclooxygenase. Eukaryotic cell 6: 346-350.
38. Erb-Downward JR, Noverr MC (2007) Characterization of Prostaglandin E2 Production by Candida albicans. Infection and immunity 75: 3498-3505.
39. Serhan CN, Gotlinger K, Hong S, Arita M (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 73: 155-172.
40. Busetto S, Trevisan E, Patriarca P, Menegazzi R (2004) A single-step, sensitive flow cytofluorometric assay for the simultaneous assessment of membrane-bound and ingested Candida albicans in phagocytosing neutrophils. Cytometry A 58: 201-206.
41. Decleva E, Menegazzi R, Busetto S, Patriarca P, Dri P (2006) Common methodology is inadequate for studies on the microbicidal activity of neutrophils. J Leukoc Biol 79: 87-94.